Le Lézard
Classified in: Science and technology, Business

Huobi NEXT meets 31 VCs, Cryptofunds and 42 Projects in Eastern Europe


PRAGUE, Nov. 12, 2018 /PRNewswire/ -- Huobi NEXT was in Prague, Czech Republic, for the first time on October 31, 2018 to meet with local European projects and community. The purpose of their trip was to allow potential projects and funds to better understand the advantages of Huobi NEXT and learn how to leverage on Huobi's Resources to create extra value.

Huobi NEXT meets 31 VCs, Cryptofunds and 42 Projects in Eastern Europe

Huobi NEXT (previously known as HADAX) is tailored to connect new and upcoming potential blockchain projects with endorsers who are interested in investing in the company and grow their capital through this platform. Interested projects will have to complete an online registration and verification process, undergo a review, and if selected, be eligible for public voting on the open platform composed of endorsers, eligible voters and HT community.

Chern Chung, Huobi Europe Business Development Lead, says, "Huobi NEXT is a good platform to get the support you need while looking for an endorser at the same time. As an endorser you can leverage Huobi's resources, assist good projects in getting listed on Huobi NEXT and attain funding, and be exposed to new projects which might not be available to public."

Alin Dumitru, Partner of Blockfront Capital, added, "I believe that being an endorser and working with Huobi is one of the most important strategies for any investment firm. This will provide you with a lot of advantages and added value. As an endorser, we are also willing to act as the backbone of Huobi in Eastern Europe and assist Huobi in exploring the Eastern European market."

Organised concurrently with JRR Crypto and Blockfront Capital, the event attracted 132 attendees including 31 Venture Capitals/CryptoFunds and 42 Projects. JRR Crypto is a Swiss-based blockchain ecosystem industry investment group. Blockfront Capital is a private investment firm which is active in Eastern Europe, with its headquarters in Switzerland and Romania, and one of the recommended institutions for Huobi in Europe.

Interested projects or endorsers can register with Huobi NEXT via the Huobi Automated Listing Platform here: www.huobi.com/application-center.

About Huobi:

Consisting of ten upstream and downstream enterprises, Huobi Group is the world's leading blockchain company. Established in 2013, Huobi Group's accumulative turnover exceeds US $1 trillion. It proudly provides safe, secure, and convenient cryptocurrency trading and asset management services to millions of users in 130+ countries.

For enquiries, please contact:
Tingyu Dong, +6585227502, [email protected] 

SOURCE Huobi Global


These press releases may also interest you

at 00:45
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: